Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activity

Anindya Goswami1, Shirley Qiu, Thomas S Dexheimer

  • 1Department of Radiation Medicine, Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky 40536, USA.

Cancer Research
|August 5, 2008
PubMed

Insights

The tumor suppressor Par-4 protein inhibits DNA relaxation by topoisomerase 1 (TOP1), a key enzyme in cancer. This interaction prevents uncontrolled DNA topology changes, suppressing cellular transformation.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • Topoisomerase 1 (TOP1) activity is crucial for DNA metabolism but is often dysregulated in cancer.
  • The mechanisms regulating TOP1 activity, particularly inhibitory pathways, remain largely unknown.
  • Identifying regulators of TOP1 is essential for understanding cancer progression and developing therapeutic strategies.

Purpose of the Study:

  • To investigate the role of the tumor suppressor protein prostate apoptosis response-4 (Par-4) in regulating TOP1 activity.
  • To elucidate the mechanism by which Par-4 interacts with and modulates TOP1 function.
  • To determine the impact of the Par-4/TOP1 interaction on DNA topology, gene transcription, and cellular transformation.

Main Methods:

  • Co-immunoprecipitation assays to demonstrate direct binding between Par-4 and TOP1.
  • In vitro DNA relaxation assays to measure TOP1 catalytic activity.
  • RNA interference (RNAi) to knock down Par-4 or TOP1 expression.
  • Analysis of gene transcription, cell cycle progression, and cellular transformation assays.

Main Results:

  • Par-4 directly binds to TOP1 through its leucine zipper domain, sequestering it from DNA.
  • Par-4 attenuates TOP1-mediated DNA relaxation activity, distinct from camptothecin's mechanism.
  • Par-4 knockdown enhances TOP1 activity, leading to increased DNA relaxation, gene transcription, and cellular transformation.
  • Overexpression of Par-4 or attenuation of TOP1 inhibits DNA relaxation, cell cycle progression, and transformation.

Conclusions:

  • Par-4 acts as an endogenous repressor of TOP1 catalytic activity.
  • The Par-4-mediated regulation of TOP1 is critical for maintaining DNA topology and suppressing cellular transformation.
  • Targeting the Par-4/TOP1 interaction may offer novel therapeutic avenues for cancer treatment.

Related Concept Videos

DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...